Markets· August 16, 2026 at 12:31 p.m.
Heartflow Inc. Surges 46% on Strong Q2 Revenue Growth and Positive Outlook
Key takeaways
- Heartflow Inc.'s stock price surged by 46%
- Q2 revenues increased by 48% to $64.08 million
- Net loss widened by 70.6% to $15.7 million
Heartflow Inc., a company specializing in artificial intelligence for diagnosing coronary artery disease, saw its stock price soar by 46% last week, making it one of the top gainers on the NASDAQ. The surge was driven by the company's strong Q2 revenue performance and optimistic outlook for the full-year period. Heartflow reported a 48% increase in Q2 revenues to $64.08 million, primarily due to growth in its US Fractional Flow Reserve business and an increase in total US Plaque revenue case volume. However, the company's net loss widened by 70.6% to $15.7 million. Despite the wider net loss, Heartflow expects full-year revenues to grow by 40-42%, up from its previous expectation of 29-32%. John Farquhar, President and CEO, attributed the growth to the company's unique AI technology platform and the under-penetrated market for detecting coronary artery disease. Several investment firms have expressed bullish sentiments towards Heartflow Inc., with Stifel, JPMorgan, and Wells Fargo raising their price targets and maintaining positive ratings. Institutional investors also increased their exposure to the company, with the number of hedge funds holding positions in Heartflow rising from 16 to 25 in the first quarter of the year.
